Concepedia

I.M. Jacobson

IJ

Statistics

Publications

5

Citations

134

H-Index

5

Active since

2011

Affiliations

Johns Hopkins University(Current)

I.M. Jacobson is an author at Johns Hopkins University specializing in pharmacotherapy, pharmacy, and viral hepatitis treatment.

Publications per year

2011–2019

5

Publications

5

8 EVOLUTION OF TREATMENT-EMERGENT RESISTANT VARIANTS IN TELAPREVIR PHASE 3 CLINICAL TRIALS

J.C. Sullivan, Sandra De Meyer, Doug J. Bartels et al. · Journal of Hepatology · 2011 · 51 citations

Life Sciences, Genetics, Pharmacotherapy +7

Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naïve european patients in the quest-1 and quest-2 phase III trials

Michael Gschwantler, GR Foster, I.M. Jacobson et al. · Zeitschrift für Gastroenterologie · 2014 · 30 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

1363 VX-222 WITH TVR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS C: ZENITH STUDY INTERIM RESULTS

Adrian M. Di Bisceglie, David R. Nelson, Edward Gane et al. · Journal of Hepatology · 2011 · 28 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Continued therapy with ABI-H0731+NRTI results in sequential reduction/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg positive patients

Sulkowski, Kosh Agarwal, SK Fung et al. · Hepatology · 2019 · 13 citations

Pharmacy, Pharmacotherapy, Hepatitis Pharmacotherapy +10

55 FUTILITY RULES IN TELAPREVIR COMBINATION TREATMENT

I.M. Jacobson, Doug J. Bartels, Linda Gritz et al. · Journal of Hepatology · 2012 · 12 citations

Pharmacy, Pharmacotherapy, Immunotherapy +1

1–5 of 5